These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27992849)

  • 1. Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.
    Zahran S; Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Environ Res; 2017 Feb; 153():181-190. PubMed ID: 27992849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.
    Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Int J Environ Res Public Health; 2015 Dec; 12(12):16124-35. PubMed ID: 26703636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.
    Mehal JM; Holman RC; Schonberger LB; Sejvar JJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):346-52. PubMed ID: 23621426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales.
    Dean G; Elian M
    J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):633-7. PubMed ID: 8509776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990-2005).
    Alonso V; Villaverde-Hueso A; Hens MJ; Morales-Piga A; Abaitua I; de la Paz MP
    Amyotroph Lateral Scler; 2011 May; 12(3):192-8. PubMed ID: 21198417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increase in mortality for motor neuron disease in Italy, 1980-1999].
    Altavista P; Belli S; Binazzi A; Comba P; Mastrantonio M; Uccelli R; Vanacore N
    Epidemiol Prev; 2006; 30(2):108-13. PubMed ID: 16909959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in motor neuron disease: association with latitude and air lead levels in Spain.
    Santurtún A; Villar A; Delgado-Alvarado M; Riancho J
    Neurol Sci; 2016 Aug; 37(8):1271-5. PubMed ID: 27098242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic Analysis of Motor Neuron Disease Mortality and Heavy Metals Released to Rivers in Spain.
    Sánchez-Díaz G; Escobar F; Badland H; Arias-Merino G; Posada de la Paz M; Alonso-Ferreira V
    Int J Environ Res Public Health; 2018 Nov; 15(11):. PubMed ID: 30423874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975 - 2004.
    Day TG; Scott M; Perring R; Doyle P
    Amyotroph Lateral Scler; 2007 Dec; 8(6):337-42. PubMed ID: 18033591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and prevalence of motor neurone disease in South Australia.
    Luker J; Woodman R; Schultz D
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):195-202. PubMed ID: 35934980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.
    Gordon PH; Artaud F; Aouba A; Laurent F; Meininger V; Elbaz A
    Eur J Epidemiol; 2011 Sep; 26(9):729-37. PubMed ID: 21674216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential features of motor neuron disease mortality in Spain.
    Veiga-Cabo J; Almazán-Isla J; Sendra-Gutiérrez JM; de Pedro-Cuesta J
    Int J Epidemiol; 1997 Oct; 26(5):1024-32. PubMed ID: 9363524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of amyotrophic lateral sclerosis.
    Kurtzke JF
    Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic distributions of motor neuron disease mortality and well water use in U.S. counties.
    Schwartz GG; Rundquist BC; Simon IJ; Swartz SE
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):279-283. PubMed ID: 28019106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998.
    Noonan CW; White MC; Thurman D; Wong LY
    Neurology; 2005 Apr; 64(7):1215-21. PubMed ID: 15824349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain cancer associated with environmental lead exposure: evidence from implementation of a National Petrol-Lead Phase-Out Program (PLPOP) in Taiwan between 1979 and 2007.
    Wu WT; Lin YJ; Liou SH; Yang CY; Cheng KF; Tsai PJ; Wu TN
    Environ Int; 2012 Apr; 40():97-101. PubMed ID: 21821291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.
    Elian M; Dean G
    Neuroepidemiology; 1992; 11(4-6):236-43. PubMed ID: 1291887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors.
    Neilson S; Gunnarsson LG; Robinson I
    Acta Neurol Scand; 1994 Sep; 90(3):150-9. PubMed ID: 7847054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the cohort effect on the trend in mortality from motor neuron disease in Spain, 19551-1002].
    Llorca Díaz J; Prieto Salceda MD; Delgado-Rodríguez M
    Rev Esp Salud Publica; 1999; 73(4):481-8. PubMed ID: 10575936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.